0.5850
-0.0300
(-4.88%)
At close: January 30 at 8:03:01 AM GMT+1
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Operating Cash Flow
-22,765.0000
-28,566.0000
1,059.0000
-23,561.0000
-19,753.0000
Investing Cash Flow
4,799.0000
46,449.0000
-46,159.0000
9,745.0000
13,038.0000
Financing Cash Flow
14,110.0000
6,423.0000
1,632.0000
36,930.0000
29,865.0000
End Cash Position
28,144.0000
35,992.0000
11,936.0000
56,277.0000
33,183.0000
Interest Paid Supplemental Data
8.0000
10.0000
13.0000
13.0000
20.0000
Capital Expenditure
-291.0000
-674.0000
-413.0000
-340.0000
-64.0000
Issuance of Capital Stock
14,070.0000
6,625.0000
148.0000
30,865.0000
5,127.0000
Issuance of Debt
--
--
--
--
25,147.0000
Repayment of Debt
-53.0000
-54.0000
-32.0000
-20.0000
-26.0000
Repurchase of Capital Stock
-23.0000
-37.0000
-17.0000
-54.0000
-27.0000
Free Cash Flow
-23,056.0000
-29,240.0000
646.0000
-23,901.0000
-19,817.0000
12/31/2020 - 7/6/2009
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
1VT.MU Viking Therapeutics Inc
33.08
0.00%
1VT.F Viking Therapeutics, Inc.
32.10
-0.86%
1VT.BE Viking Therapeutics Inc
32.18
-0.06%
SER Serina Therapeutics, Inc.
4.6000
-0.65%
ONWD.BR Onward Medical N.V.
6.30
-4.55%
CRIS Curis, Inc.
3.2900
+2.17%
TRAW Traws Pharma, Inc.
7.29
0.00%
RKV.V Rakovina Therapeutics Inc.
0.1900
-2.56%
MNPR Monopar Therapeutics Inc.
42.50
+9.54%
TPST Tempest Therapeutics, Inc.
0.9450
+5.35%